Efficacy and Safety Study of Meloxicam Nanocrystal Injection for the Treatment of Moderate to Severe Pain After Abdominal Surgery - a Multicenter, Randomized, Double-blind, Placebo-parallel Controlled, Phase III Clinical Trial
Latest Information Update: 29 Apr 2024
At a glance
- Drugs Meloxicam (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors CSPC ZhongQi Pharmaceutical Technology
Most Recent Events
- 29 Apr 2024 New trial record